![]() |
Influenza |
Free Subscription
1 Biochem Biophys Res Commun |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Influenza is free of charge.
High-resolution structure reveals enhanced 14-3-3 binding by a mutant SARS-CoV-2
nucleoprotein variant with improved replicative fitness.
Biochem Biophys Res Commun. 2025;767:151915.
PubMed
Abstract available
The impact of pre-existing immunity on the emergence of within-host immune-escape
mutations in Omicron lineages.
J Gen Virol. 2025;106:002108.
PubMed
Abstract available
Tollip deficiency enhances mitophagy and reduces STING activation in influenza A
virus-infected mice.
J Immunol. 2025 May 16:vkaf058. doi: 10.1093.
PubMed
Abstract available
Estimating Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza
Using Linked Public Health Information Systems, California, 2023-2024 Season.
J Infect Dis. 2025 May 13:jiaf248. doi: 10.1093.
PubMed
Abstract available
Binding antibody titers against the hemagglutinin and neuraminidase correlate
with protection against medically attended influenza A and B disease.
J Virol. 2025 May 13:e0039125. doi: 10.1128/jvi.00391.
PubMed
Abstract available
Developing Zika virus-transduced hACE2 expression models for severe acute
respiratory syndrome coronavirus 2 infection in vitro and in vivo.
J Virol Methods. 2025 Apr 14:115166. doi: 10.1016/j.jviromet.2025.115166.
PubMed
Abstract available
Optimization of an infectious subgenomic amplicons reverse genetics protocol for
the rescue of synthetic coronaviruses.
J Virol Methods. 2025;336:115152.
PubMed
Abstract available
Design of nanobody targeting SARS-CoV-2 spike glycoprotein using CDR-grafting
assisted by molecular simulation and machine learning.
PLoS Comput Biol. 2025;21:e1012921.
PubMed
Abstract available
A conceptual and computational framework for modeling the complex, adaptive
dynamics of epidemics: The case of the SARS-CoV-2 pandemic in Mexico.
PLoS One. 2025;20:e0323473.
PubMed
Abstract available
Disentangling behavioral determinants of seasonal influenza vaccination in
post-corona era: An integrated model approach.
PLoS One. 2025;20:e0323184.
PubMed
Abstract available
Maternal and infant health during the COVID-19 pandemic - A Pennsylvania Study
Protocol.
PLoS One. 2025;20:e0323891.
PubMed
Abstract available
The global response to the pandemic: An empirical cluster analysis of policies
targeting COVID-19.
PLoS One. 2025;20:e0322692.
PubMed
Abstract available
A comparative analysis of large language models versus traditional information
extraction methods for real-world evidence of patient symptomatology in acute and
post-acute sequelae of SARS-CoV-2.
PLoS One. 2025;20:e0323535.
PubMed
Abstract available
Self-reported health, neuropsychological tests and biomarkers in fully recovered
COVID-19 patients vs patients with post-COVID cognitive symptoms: A pilot study.
PLoS One. 2025;20:e0315486.
PubMed
Abstract available
The differential burden of acute rhinovirus infections in children with
underlying conditions.
PLoS One. 2025;20:e0313237.
PubMed
Abstract available
Effective remediation programs for vulnerable students to overcome learning loss.
PLoS One. 2025;20:e0323352.
PubMed
Abstract available
Association between early-pandemic food assistance use and subsequent food
security trajectories among households in Washington State during the first three
years of the COVID-19 pandemic.
PLoS One. 2025;20:e0321585.
PubMed
Abstract available
Expectations regarding the effectiveness of mask-wearing and pandemic fatigue:
The experience in Japan.
PLoS One. 2025;20:e0321402.
PubMed
Abstract available
Universal health care delivery mitigates socioeconomic-related risk for adverse
outcomes in hospitalised patients: Lessons from the COVID-19 pandemic in
Australia.
PLoS One. 2025;20:e0322780.
PubMed
Abstract available
Efficacy of BCG vaccination against COVID-19 in health care workers and
non-health care workers: A meta-analysis of randomized controlled trials.
PLoS One. 2025;20:e0321511.
PubMed
Abstract available
Differences in COVID-19 testing perceptions among caregivers of children with
medical complexity by rurality.
PLoS One. 2025;20:e0323651.
PubMed
Abstract available
Economic impact and disease burden of COVID-19 in a tertiary care hospital: A
three-year analysis.
PLoS One. 2025;20:e0323200.
PubMed
Abstract available
Impact of prior SARS-CoV-2 infection on perioperative cardiac, pulmonary and
neurocognitive complications in older patients: Study protocol for an observative
case control study.
PLoS One. 2025;20:e0323599.
PubMed
Abstract available
Infectious potential and circulation of SARS-CoV-2 in wild rats.
PLoS One. 2025;20:e0316882.
PubMed
Abstract available
Construction and application of SARS-CoV-2 protein ontology (CoVPO).
PLoS One. 2025;20:e0317589.
PubMed
Abstract available
The relationships among nurses' spiritual health, sleep quality, and stress and
the factors influencing stress during the late global COVID-19 pandemic: A cross-
sectional study.
PLoS One. 2025;20:e0323164.
PubMed
Abstract available
What drives the effectiveness of social distancing in combating COVID-19 across
U.S. states?
PLoS One. 2025;20:e0308244.
PubMed
Abstract available
Using smart transportation assets to hedge fossil energy markets: Evidence from
quantile-based VAR approach.
PLoS One. 2025;20:e0317748.
PubMed
Abstract available
A protocol for high-dose quadrivalent influenza vaccine effectiveness in the
community and long-term care facilities using electronic health records.
PLoS One. 2025;20:e0314177.
PubMed
Abstract available
Computerized neuropsychological assessment in post-COVID condition.
PLoS One. 2025;20:e0322304.
PubMed
Abstract available
Waning of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19
pandemic in 2020: A 12-month-evaluation in three population-based European
studies.
PLoS One. 2025;20:e0320196.
PubMed
Abstract available
Study on measurement and prediction of agricultural product supply chain
resilience based on improved EW-TOPSIS and GM (1,1)-Markov models under public
emergencies.
PLoS One. 2025;20:e0321248.
PubMed
Abstract available
Association of mental health, quality of life, and SARS-CoV-2 infection in
individuals in need of care: Results from a multicentre registry study.
PLoS One. 2025;20:e0323017.
PubMed
Abstract available
Mask wearing as a prosocial behavior: Proposing and testing the moral norms
activation model.
PLoS One. 2025;20:e0322921.
PubMed
Abstract available
COVIVA: Effect of transcutaneous auricular vagal nerve stimulation on
fatigue-syndrome in patients with Long Covid - A placebo-controlled pilot study
protocol.
PLoS One. 2025;20:e0315606.
PubMed
Abstract available
A rapid human vaccine process development map outlining lessons learnt from
ChAdOx1 nCoV-19 vaccine during the COVID-19 pandemic.
Vaccine. 2025;55:127040.
PubMed
Abstract available
Sociodemographic differences in parental hesitancy to the COVID-19 vaccine.
Vaccine. 2025;55:127041.
PubMed
Abstract available
Identification of potential vaccines for use with microarray patches in low- and
middle-income countries: An assessment from the Vaccine Innovation Prioritisation
Strategy Alliance.
Vaccine. 2025;55:126996.
PubMed
Abstract available
Factors influencing acceptance of RSV immunization for newborns among pregnant
individuals: A mixed-methods study.
Vaccine. 2025;55:127062.
PubMed
Abstract available
Sociodemographic and health-related predictors of COVID-19 booster uptake among
fully vaccinated adults.
Vaccine. 2025;54:127048.
PubMed
Abstract available
A rapid cycle analytics framework for vaccine safety surveillance within a
real-world data network: Experience with enhanced surveillance of the Janssen
COVID-19 vaccine.
Vaccine. 2025;55:127044.
PubMed
Abstract available
Evaluation of the costs of care for pediatric patients hospitalized for RSV: A
retrospective cohort study in Belgium.
Vaccine. 2025;55:127065.
PubMed
Abstract available
Vaccine hesitancy among racially diverse parents in Canada: The important role of
health literacy, conspiracy beliefs and racial discrimination.
Vaccine. 2025;55:127049.
PubMed
Abstract available
Estimation of trajectory of COVID-19 vaccines effectiveness against infection.
Vaccine. 2025;55:127067.
PubMed
Abstract available
Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted
RBD-based protein booster vaccines in adults previously immunized with different
vaccine platforms: A phase II/III, randomized clinical trial.
Vaccine. 2025;54:127045.
PubMed
Abstract available
Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant
spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive
participants: Primary day-28 analysis of a phase 2/3 open-label study.
Vaccine. 2025;55:127046.
PubMed
Abstract available
Effectiveness of 2023-2024 COVID-19 vaccines against COVID-19-associated
hospitalizations among adults aged >/=18 years with end stage kidney disease -
United States, September 2023-April 2024.
Vaccine. 2025;55:127010.
PubMed
Abstract available
"Better to die trying": Vaccine perceptions and COVID-19 experiences in rural
Namibian pastoralists.
Vaccine. 2025;55:127061.
PubMed
Abstract available
Pharmacy and healthcare provider offices as convenient adult vaccination settings
in the US: Patient experiences from a survey of recently-vaccinated adults.
Vaccine. 2025;54:127057.
PubMed
Abstract available
Hybrid, vaccine-induced and natural immunity against SARS-CoV-2 in traditional
food markets in Bolivia (2020-2022): A cross-sectional analysis of a serological
survey.
Vaccine. 2025;54:127104.
PubMed
Abstract available
Opportunities and challenges for the adoption of novel platform technologies to
develop veterinary bacterial vaccines.
Vaccine. 2025;54:127117.
PubMed
Abstract available
Strengthening health security through routine vaccination policy: A comprehensive
analysis of childhood vaccination laws across 194 countries.
Vaccine. 2025;54:127121.
PubMed
Abstract available
Evaluating concurrency and gaps between self-report and vaccine card data for
COVID-19 vaccination.
Vaccine. 2025;54:127136.
PubMed
Abstract available
Nationwide population-based surveillance of invasive pneumococcal disease in
children in Japan (2014-2022): Impact of 13-valent pneumococcal conjugate vaccine
and COVID-19 pandemic.
Vaccine. 2025;54:127138.
PubMed
Abstract available
Corrigendum to "Cross-protection against H7N9 influenza strains using a
live-attenuated H7N3 virus vaccine" [Vaccine (2015) 33(1) 108-16].
Vaccine. 2025;57:127174.
PubMed
Practice, beliefs and intent in influenza vaccination among Hispanic patients
during the pandemic: An interventional study.
Vaccine. 2025;58:127207.
PubMed
Abstract available
Applying the health belief model (HBM) to understand COVID-19 vaccine uptake
among youth and young adults: Findings from a 6-month follow-up study in the
United States.
Vaccine. 2025;54:127002.
PubMed
Abstract available
Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate
vaccine.
Vaccine. 2025;54:126989.
PubMed
Abstract available
Health care institutions and their physicians are the greatest promoters of
COVID-19 vaccine acceptance among health care workers.
Vaccine. 2025;54:127005.
PubMed
Abstract available
The direct impact of mandatory PCV10 vaccination on invasive pneumococcal disease
in Polish children.
Vaccine. 2025;54:126999.
PubMed
Abstract available
Childhood vaccination coverages in rural Guinea-Bissau before and during the
early COVID-19 pandemic, a cohort study.
Vaccine. 2025;54:127011.
PubMed
Abstract available
A review of Canadian online resources providing information on COVID-19
vaccination for caregivers of children aged 5-11 years.
Vaccine. 2025;54:126990.
PubMed
Abstract available
Comparison of Streptococcus pneumoniae nasopharyngeal colonization,
serotype-specific and protein-specific antibody and cytokine levels in young
children prior to, during and post COVID-19 pandemic.
Vaccine. 2025;54:126954.
PubMed
Abstract available
Efficacy of BCG vaccination on incidence, severity and clinical progression of
COVID-19: A BCG-REVAC population analysis.
Vaccine. 2025;54:126911.
PubMed
Abstract available
Pregnant persons perceptions and uptake of prenatal RSV vaccine - Minnesota,
2023-2024.
Vaccine. 2025;54:126958.
PubMed
Abstract available
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1
in the assessment of vaccination and therapeutics.
Vaccine. 2025;54:126960.
PubMed
Abstract available
mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses
against the JN.1 sublineages of SARS-CoV-2 in mice.
Vaccine. 2025;54:126961.
PubMed
Abstract available
SARS-CoV-2 conjugate vaccine elicits robust immune responses that can protect
against evolving variants.
Vaccine. 2025;54:126988.
PubMed
Abstract available
Durability of COVID-19 vaccine and infection induced immunity: A systematic
review and meta-regression analysis.
Vaccine. 2025;54:126966.
PubMed
Abstract available
Anti-vaccine attitudes and COVID-19 vaccine status at the end of the U.S. public
health emergency.
Vaccine. 2025;55:127003.
PubMed
Abstract available
Socio-demographic differences in citizen' preferences for distributing a scarce,
lifesaving resource: A case study using COVID-19 vaccine distribution in Belgium.
Vaccine. 2025;55:126997.
PubMed
Abstract available
Predicting immune protection against outcomes of infectious disease from
population-level effectiveness data with application to COVID-19.
Vaccine. 2025;55:126987.
PubMed
Abstract available
Concordance between parent-reported and documented COVID-19 vaccination status
among hospitalized children and adolescents: Implications for vaccine
effectiveness estimates, May 2021-October 2023.
Vaccine. 2025;54:126891.
PubMed
Abstract available
Quantification of objective concentrations of DNA impurities in mRNA vaccines.
Vaccine. 2025;55:127022.
PubMed
Abstract available
Alcohol consumption does not influence SARS-CoV-2 vaccine immunogenicity: A stop
the spread Ottawa cohort analysis.
Vaccine. 2025;55:127034.
PubMed
Abstract available
Adverse events among early caregivers' COVID-19 vaccination correlated inversely
with intention to vaccinate their children.
Vaccine. 2025;55:127001.
PubMed
Abstract available
Exploring the pathogenic and transmission characteristics of JN.1 in golden
hamsters based on different attack methods.
Virology. 2025;608:110548.
PubMed
Abstract available
A phycobiliprotein-based reporter assay for the evaluation of SARS-CoV-2 main
protease activity.
Virology. 2025;608:110540.
PubMed
Abstract available
Thank you for your interest in scientific medicine.